Generation Bio Co. Statistics
Share Statistics
Generation Bio Co. has 66.79M shares outstanding. The number of shares has increased by 1% in one year.
| Shares Outstanding | 66.79M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | 0.32% |
| Owned by Institutions (%) | n/a |
| Shares Floating | 42.51M |
| Failed to Deliver (FTD) Shares | 106 |
| FTD / Avg. Volume | 0.07% |
Short Selling Information
The latest short interest is 1.66M, so 2.48% of the outstanding shares have been sold short.
| Short Interest | 1.66M |
| Short % of Shares Out | 2.48% |
| Short % of Float | 3.62% |
| Short Ratio (days to cover) | 17.16 |
Valuation Ratios
The PE ratio is -0.84 and the forward PE ratio is -1.85.
| PE Ratio | -0.84 |
| Forward PE | -1.85 |
| PS Ratio | 18.02 |
| Forward PS | 11.8 |
| PB Ratio | 0.52 |
| P/FCF Ratio | -1.77 |
| PEG Ratio | n/a |
Enterprise Valuation
Generation Bio Co. has an Enterprise Value (EV) of 137.85M.
| EV / Earnings | -1.09 |
| EV / Sales | 23.35 |
| EV / EBITDA | -1.03 |
| EV / EBIT | -0.99 |
| EV / FCF | -2.29 |
Financial Position
The company has a current ratio of 6.83, with a Debt / Equity ratio of 0.05.
| Current Ratio | 6.83 |
| Quick Ratio | 6.83 |
| Debt / Equity | 0.05 |
| Total Debt / Capitalization | 4.82 |
| Cash Flow / Debt | -5.12 |
| Interest Coverage | 0 |
Financial Efficiency
Return on equity (ROE) is -0.62% and return on capital (ROIC) is -46.03%.
| Return on Equity (ROE) | -0.62% |
| Return on Assets (ROA) | -0.34% |
| Return on Capital (ROIC) | -46.03% |
| Revenue Per Employee | 33.93K |
| Profits Per Employee | -727.66K |
| Employee Count | 174 |
| Asset Turnover | 0.02 |
| Inventory Turnover | -424.55 |
Taxes
| Income Tax | 0 |
| Effective Tax Rate | 0 |
Stock Price Statistics
The stock price has increased by -42.5% in the last 52 weeks. The beta is 2.82, so Generation Bio Co.'s price volatility has been higher than the market average.
| Beta | 2.82 |
| 52-Week Price Change | -42.5% |
| 50-Day Moving Average | 1.9 |
| 200-Day Moving Average | 2.69 |
| Relative Strength Index (RSI) | 25.86 |
| Average Volume (20 Days) | 157.31K |
Income Statement
In the last 12 months, Generation Bio Co. had revenue of $5.90M and earned -$126.61M in profits. Earnings per share was $-1.96.
| Revenue | 5.90M |
| Gross Profit | -73.91M |
| Operating Income | -138.56M |
| Net Income | -126.61M |
| EBITDA | -133.30M |
| EBIT | -138.56M |
| Earnings Per Share (EPS) | -1.96 |
Balance Sheet
The company has $66.45M in cash and $97.89M in debt, giving a net cash position of -$31.45M.
| Cash & Cash Equivalents | 66.45M |
| Total Debt | 97.89M |
| Net Cash | -31.45M |
| Retained Earnings | -571.38M |
| Total Assets | 248.78M |
| Working Capital | 161.09M |
Cash Flow
In the last 12 months, operating cash flow was -$52.74M and capital expenditures -$7.40M, giving a free cash flow of -$60.14M.
| Operating Cash Flow | -52.74M |
| Capital Expenditures | -7.40M |
| Free Cash Flow | -60.14M |
| FCF Per Share | -0.93 |
Margins
Gross margin is -1.25K%, with operating and profit margins of -2.35K% and -2.14K%.
| Gross Margin | -1.25K% |
| Operating Margin | -2.35K% |
| Pretax Margin | -2.14K% |
| Profit Margin | -2.14K% |
| EBITDA Margin | -2.26K% |
| EBIT Margin | -2.35K% |
| FCF Margin | -1.02K% |
Dividends & Yields
GBIO does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Payout Ratio | n/a |
| Earnings Yield | -170.43% |
| FCF Yield | -78.37% |
Analyst Forecast
The average price target for GBIO is $7.5, which is 552.2% higher than the current price. The consensus rating is "Buy".
| Price Target | $7.5 |
| Price Target Difference | 552.2% |
| Analyst Consensus | Buy |
| Analyst Count | 2 |
Scores
| Altman Z-Score | -3.95 |
| Piotroski F-Score | 3 |